Combination therapy for visceral leishmaniasis
- PMID: 21255829
- DOI: 10.1016/S0140-6736(10)62237-4
Combination therapy for visceral leishmaniasis
Comment on
-
Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial.Lancet. 2011 Feb 5;377(9764):477-86. doi: 10.1016/S0140-6736(10)62050-8. Epub 2011 Jan 20. Lancet. 2011. PMID: 21255828 Clinical Trial.
Similar articles
-
Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial.Lancet. 2011 Feb 5;377(9764):477-86. doi: 10.1016/S0140-6736(10)62050-8. Epub 2011 Jan 20. Lancet. 2011. PMID: 21255828 Clinical Trial.
-
Treatment of visceral leishmaniasis in 2010: direction from Bihar State, India.Future Microbiol. 2010 Sep;5(9):1301-3. doi: 10.2217/fmb.10.92. Future Microbiol. 2010. PMID: 20860475 No abstract available.
-
Safety and efficacy of a combination of paromomycin and miltefosine for two vs. three courses in patients with post-kala-azar dermal leishmaniasis: an observational pilot study.Br J Dermatol. 2017 Aug;177(2):557-559. doi: 10.1111/bjd.15119. Epub 2017 Jul 2. Br J Dermatol. 2017. PMID: 27781268 Clinical Trial. No abstract available.
-
Visceral leishmaniasis: elimination with existing interventions.Lancet Infect Dis. 2011 Apr;11(4):322-5. doi: 10.1016/S1473-3099(10)70320-0. Lancet Infect Dis. 2011. PMID: 21453873 Review.
-
Amphotericin B for treatment of visceral leishmaniasis: systematic review and meta-analysis of prospective comparative clinical studies including dose-ranging studies.Clin Microbiol Infect. 2018 Jun;24(6):591-598. doi: 10.1016/j.cmi.2017.11.008. Epub 2017 Nov 11. Clin Microbiol Infect. 2018. PMID: 29138100 Review.
Cited by
-
Current Applications of Plant-Based Drug Delivery Nano Systems for Leishmaniasis Treatment.Pharmaceutics. 2022 Oct 29;14(11):2339. doi: 10.3390/pharmaceutics14112339. Pharmaceutics. 2022. PMID: 36365157 Free PMC article. Review.
-
Leishmaniasis: A new method for confirming cure and detecting asymptomatic infection in patients receiving immunosuppressive treatment for autoimmune disease.PLoS Negl Trop Dis. 2021 Aug 2;15(8):e0009662. doi: 10.1371/journal.pntd.0009662. eCollection 2021 Aug. PLoS Negl Trop Dis. 2021. PMID: 34339445 Free PMC article.
-
Using Q-methodology to understand the perspectives and practical experiences of dermatologists about treatment difficulties of cutaneous leishmaniasis.BMC Infect Dis. 2020 Sep 1;20(1):645. doi: 10.1186/s12879-020-05365-0. BMC Infect Dis. 2020. PMID: 32873242 Free PMC article.
-
Field effectiveness of new visceral leishmaniasis regimens after 1 year following treatment within public health facilities in Bihar, India.PLoS Negl Trop Dis. 2019 Sep 26;13(9):e0007726. doi: 10.1371/journal.pntd.0007726. eCollection 2019 Sep. PLoS Negl Trop Dis. 2019. PMID: 31557162 Free PMC article.
-
A chronic bioluminescent model of experimental visceral leishmaniasis for accelerating drug discovery.PLoS Negl Trop Dis. 2019 Feb 14;13(2):e0007133. doi: 10.1371/journal.pntd.0007133. eCollection 2019 Feb. PLoS Negl Trop Dis. 2019. PMID: 30763330 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources